Ferring International Center S.A. - Product Pipeline Review - 2016

  • ID: 3635636
  • Company Profile
  • Region: Global
  • 49 pages
  • Global Markets Direct
1 of 4
Ferring International Center S.A. - Product Pipeline Review - 2016

Summary

The report ‘Ferring International Center S.A. - Product Pipeline Review - 2016’, provides an overview of the Ferring International Center S.A.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ferring International Center S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Ferring International Center S.A.
- The report provides overview of Ferring International Center S.A. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Ferring International Center S.A.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Ferring International Center S.A.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Ferring International Center S.A.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Ferring International Center S.A.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Ferring International Center S.A.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Ferring International Center S.A. Snapshot

Ferring International Center S.A. Overview

Key Information

Key Facts

Ferring International Center S.A. - Research and Development Overview

Key Therapeutic Areas

Ferring International Center S.A. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Ferring International Center S.A. - Pipeline Products Glance

Ferring International Center S.A. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Ferring International Center S.A. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Ferring International Center S.A. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Ferring International Center S.A. - Drug Profiles

follitropin delta

Product Description

Mechanism of Action

R&D Progress

Testavan

Product Description

Mechanism of Action

R&D Progress

degarelix acetate

Product Description

Mechanism of Action

R&D Progress

elobixibat

Product Description

Mechanism of Action

R&D Progress

selepressin

Product Description

Mechanism of Action

R&D Progress

barusiban

Product Description

Mechanism of Action

R&D Progress

carbetocin

Product Description

Mechanism of Action

R&D Progress

FE-999301

Product Description

Mechanism of Action

R&D Progress

merotocin

Product Description

Mechanism of Action

R&D Progress

FE-201874

Product Description

Mechanism of Action

R&D Progress

FE-204038

Product Description

Mechanism of Action

R&D Progress

FE-999310

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Undisclosed Indication

Product Description

Mechanism of Action

R&D Progress

Ferring International Center S.A. - Pipeline Analysis

Ferring International Center S.A. - Pipeline Products by Target

Ferring International Center S.A. - Pipeline Products by Route of Administration

Ferring International Center S.A. - Pipeline Products by Molecule Type

Ferring International Center S.A. - Pipeline Products by Mechanism of Action

Ferring International Center S.A. - Recent Pipeline Updates

Ferring International Center S.A. - Dormant Projects

Ferring International Center S.A. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

DR-2011

Ferring International Center S.A. - Locations and Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Ferring International Center S.A., Key Information

Ferring International Center S.A., Key Facts

Ferring International Center S.A. - Pipeline by Indication, 2016

Ferring International Center S.A. - Pipeline by Stage of Development, 2016

Ferring International Center S.A. - Monotherapy Products in Pipeline, 2016

Ferring International Center S.A. - Partnered Products in Pipeline, 2016

Ferring International Center S.A. - Partnered Products/ Combination Treatment Modalities, 2016

Ferring International Center S.A. - Out-Licensed Products in Pipeline, 2016

Ferring International Center S.A. - Out-Licensed Products/ Combination Treatment Modalities, 2016

Ferring International Center S.A. - Pre-Registration, 2016

Ferring International Center S.A. - Phase III, 2016

Ferring International Center S.A. - Phase II, 2016

Ferring International Center S.A. - Preclinical, 2016

Ferring International Center S.A. - Pipeline by Target, 2016

Ferring International Center S.A. - Pipeline by Route of Administration, 2016

Ferring International Center S.A. - Pipeline by Molecule Type, 2016

Ferring International Center S.A. - Pipeline Products by Mechanism of Action, 2016

Ferring International Center S.A. - Recent Pipeline Updates, 2016

Ferring International Center S.A. - Dormant Developmental Projects,2016

Ferring International Center S.A. - Discontinued Pipeline Products, 2016

Ferring International Center S.A., Other Locations

Ferring International Center S.A., Subsidiaries

List of Figures

Ferring International Center S.A. - Pipeline by Top 10 Indication, 2016

Ferring International Center S.A. - Pipeline by Stage of Development, 2016

Ferring International Center S.A. - Monotherapy Products in Pipeline, 2016

Ferring International Center S.A. - Out-Licensed Products in Pipeline, 2016

Ferring International Center S.A. - Pipeline by Target, 2016

Ferring International Center S.A. - Pipeline by Route of Administration, 2016

Ferring International Center S.A. - Pipeline by Molecule Type, 2016

Ferring International Center S.A. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll